Xavo announces its participation in the SLAS 2024 Conference & Exhibition

Xavo announces its participation in the SLAS2024 International Conference and Exhibition

Xavo, a leading provider of Software-as-a-Service for Biopharma R&D with offices in Boston, MA, Bayreuth, Germany and Basel, Switzerland, is attending the SLAS2024 International Conference and Exhibition from February 3th – 7th, 2024 in Boston. In the exhibition space of the conference, Xavo demonstrates its unique transformative approach to Sample Management Software.

As part of Xavo’s mission to accelerate the Biopharma R&D value chain, Xavo is continuously enabling Sample Management in Biopharma R&D by addressing the strategic problem of optimally fulfilling demand in the form of material requests based on available finite lab capacity and material inventory. Xavo R3 helps Sample Management groups to consistently deliver the right material in the right format to the right recipient in the right quality to promise on time every time by providing the best combination of functional and non-functional means.

At the 2024 SLAS exhibition, Xavo for the first time will demonstrate the AIassisted Copilot solution to emphasize that it has developed new ways to address latest trends and challenges in the Sample Management realm. Xavo has reimagined how Sample Management Software can actively assist scientific service providers to get their important job done optimally by providing the best combination of functional and non-functional means through its Softwareas-a-Service, ‘Xavo R3’.